{"id":33746,"date":"2020-10-28T08:43:46","date_gmt":"2020-10-28T12:43:46","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=33746"},"modified":"2020-10-28T08:48:43","modified_gmt":"2020-10-28T12:48:43","slug":"the-covid-vaccine-trials-are-rigged","status":"publish","type":"post","link":"http:\/\/stateofthenation.co\/?p=33746","title":{"rendered":"THE COVID VACCINE TRIALS ARE RIGGED!"},"content":{"rendered":"<h1><strong>How COVID-19 Vaccine Trials Are Rigged<\/strong><\/h1>\n<p><!--more-->Analysis by Dr. Joseph Mercola<\/p>\n<div id=\"bcr_UpdPnlStory\">\n<div id=\"bcr_pnlStoryAtAGlance\" class=\"story-glance\">\n<div class=\"story-highlights\">\n<h3 id=\"expanderHead\" data-jsid=\"expanderHead\">Story at-a-glance<\/h3>\n<div id=\"expanderContent\" data-jsid=\"expanderContent\">\n<ul>\n<li><span id=\"bcr_rptStory_cslStory_0\">While vaccine makers insist any COVID-19 vaccine reaching the market will have undergone rigorous testing, the way trial protocols are designed suggests these vaccines will not have a significant impact on infection rates, hospitalizations or deaths<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_1\">Shockingly, preventing infection with SARS-CoV-2 is not a criterion for success in these vaccine trials. The only criterion for a successful COVID-19 vaccine is a reduction of symptoms shared by both COVID-19 and the common cold<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_2\">In AstraZeneca\u2019s case, the interim analysis includes 50 vaccine recipients. The vaccine will be a success if 12 or fewer develop symptoms after exposure to SARS-CoV-2, compared to 19 in the 25-person control group<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_3\">At least two cases of transverse myelitis (severe inflammation of the spinal cord) has been documented in AstraZeneca\u2019s trial, and the company temporarily halted its trial in September 2020. In October, Johnson &amp; Johnson also paused its trial due to an undisclosed \u201cunexplained illness\u201d in one of its participants<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_4\">If the vaccine cannot reduce infection, hospitalization or death, then it cannot end the pandemic, which means everyone who takes the vaccine will be doing so in vain<\/span><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"bodytext\" class=\"bodytextdiv\">\n<p>There\u2019s been a lot of talk lately about whether or not the fast-tracked COVID-19 vaccine will in fact be safe and effective. While vaccine makers insist that any vaccine reaching the market will have undergone rigorous testing, the way trial protocols are designed suggests these vaccines may leave a lot to be desired.<\/p>\n<p>As reported<sup><span id=\"edn1\" data-hash=\"#ednref1\">1<\/span><\/sup> by Forbes contributor William Haseltine, a former professor at Harvard Medical School and Harvard School of Public Health, while Moderna, Pfizer, AstraZeneca and Johnson &amp; Johnson have all published their vaccine trial protocols in a rare display of transparency, \u201cclose inspection of the protocols raises surprising concerns.\u201d<\/p>\n<p>In a nutshell, the trial designs are such that the vaccines will get a passing grade even if their efficacy is minimal. Of course, we must also consider vaccine side effects and I\u2019ve also written several articles about mounting <a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/09\/22\/warp-speed-vaccine-will-be-shielded-from-liability.aspx\">safety concerns<\/a>.<\/p>\n<h2>COVID-19 Vaccine Trials Rigged to Pass Efficacy Test<\/h2>\n<p>As noted by Haseltine, prevention of infection would typically be a critical endpoint of any vaccine trial. In other words, you want to ensure that when you take the vaccine, your risk of infection is significantly reduced.<\/p>\n<p>However, when it comes to the COVID-19 vaccine, shockingly, preventing infection is not a criterion for success in any of these trials. The only criterion for a successful COVID-19 vaccine is a reduction of COVID-19 symptoms, and even then, the reduction required is minimal.<\/p>\n<blockquote><p><em>\u201cWe all expect an effective vaccine to prevent serious illness if infected. Three of the vaccine protocols \u2014 Moderna, Pfizer, and AstraZeneca \u2014 do not require that their vaccine prevent serious disease only that they prevent moderate symptoms which may be as mild as cough, or headache,\u201d <\/em>Haseltine writes,<sup><span id=\"edn2\" data-hash=\"#ednref2\">2<\/span><\/sup> adding:<\/p><\/blockquote>\n<blockquote><p><em>\u201cThe pharmaceutical companies intend to do trials ranging from 30,000 to 60,000 participants. This scale of study would be sufficient for testing vaccine efficacy. <\/em><\/p><\/blockquote>\n<blockquote><p><em>The first surprise found upon a closer reading of the protocols reveals that each study intends to complete interim and primary analyses that at most include 164 participants. These companies likely intend to apply for an emergency use authorization (EUA) from the Food and Drug Administration (FDA) with just their limited preliminary results.\u201d<\/em><\/p><\/blockquote>\n<p>To get a \u201cpassing\u201d grade in the limited interim analysis, a vaccine must show a 70% efficacy. However, again, this does not mean it will prevent infection in 7 of 10 people. As explained by Haseltine:<sup><span id=\"edn3\" data-hash=\"#ednref3\">3<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cFor Moderna, the initial interim analysis will be based on the results of infection of only 53 people. The judgment reached in interim analysis is dependent upon the difference in the number of people with symptoms \u2026 in the vaccinated group versus the unvaccinated group. Moderna\u2019s success margin is for 13 or less of those 53 to develop symptoms compared to 40 or more in their control group.\u201d <\/em><\/p><\/blockquote>\n<p>The other vaccine makers are basing results on a similar protocol, where only a limited number of vaccinated participants are exposed to the virus to evaluate the extent of their symptoms.<\/p>\n<p>Johnson &amp; Johnson\u2019s interim analysis will include results from 77 vaccine recipients who have been infected with SARS-CoV-2, and if fewer than 18 of them develop symptoms of COVID-19, compared to 59 in the control group, the vaccine will be considered successful.<\/p>\n<p>In AstraZeneca\u2019s case, the interim analysis includes 50 vaccine recipients. The vaccine will be a success if 12 or fewer develop symptoms after exposure to SARS-CoV-2, compared to 19 in the 25-person control group.<\/p>\n<p>Pfizer\u2019s interim analysis is the smallest of the bunch, with just 32 vaccine recipients. Their success margin is seven or fewer vaccine recipients developing symptoms, compared to 25 in the control group. In the primary analysis, efficacy is set to about 60%, and at most, 164 volunteers will be included in that analysis.<\/p>\n<p>Especially concerning are that those receiving the vaccine in these trials are young and healthy individuals who are not really at high risk of dying from COVID-19. This makes the results of these trials highly questionable in the far more vulnerable population of the elderly.<\/p>\n<div class=\"productad\"><\/div>\n<h2>Trials Are Merely Testing Reduction of Common Cold Symptoms<\/h2>\n<p>As if that\u2019s not eyebrow-raising enough, the minimum qualification for a \u201ccase of COVID-19\u201d amounts to just one positive PCR test and one or two mild symptoms, such as headache, fever, cough or mild nausea. As noted by Haseltine, \u201cThis is far from adequate.\u201d<\/p>\n<p>All they\u2019re doing is testing to see if this COVID-19 vaccine will minimize common cold symptoms. They are not actually ensuring the vaccine will prevent serious COVID-19 complications. Johnson &amp; Johnson\u2019s trial is the only one that requires at least five severe COVID-19 cases to be included in the interim analysis.<\/p>\n<blockquote><p><em>\u201cOne of the more immediate questions a trial needs to answer is whether a vaccine prevents infection. If someone takes this vaccine, are they far less likely to become infected with the virus? <\/em><\/p><\/blockquote>\n<blockquote><p><em>These trials all clearly focus on eliminating symptoms of COVID-19, and not infections themselves. Asymptomatic infection is listed as a secondary objective in these trials when they should be of critical importance. <\/em><\/p><\/blockquote>\n<blockquote><p><em>It appears that all the pharmaceutical companies assume that the vaccine will never prevent infection. Their criteria for approval is the difference in symptoms between an infected control group and an infected vaccine group. They do not measure the difference between infection and noninfection as a primary motivation,\u201d<\/em> Haseltine writes.<sup><span id=\"edn4\" data-hash=\"#ednref4\">4<\/span><\/sup><\/p><\/blockquote>\n<p>Severe illness and death are also secondary objectives in these trials, and none of them include failure to prevent hospitalization or death as an important barrier to success. The increasingly disappearing common sense tells us that if the vaccine cannot reduce infection, hospitalization or death, then it cannot end the pandemic, which means everyone who takes the vaccine will be doing so in vain.<\/p>\n<h2>Some COVID-19 Vaccine Trials Are Not Using Inert Placebos<\/h2>\n<p>In addition to all of that, some COVID-19 vaccine trials are using other vaccines as \u201cplacebo\u201d rather than truly biologically inert substances such as saline, which effectively makes if far easier to hide any vaccine side effects. While Moderna is using a saline solution placebo,<sup><span id=\"edn5\" data-hash=\"#ednref5\">5<\/span><\/sup> AstraZeneca is using injected meningococcal vaccine rather than a true placebo.<sup><span id=\"edn6\" data-hash=\"#ednref6\">6<\/span><\/sup><\/p>\n<p>Another way AstraZeneca is masking potential side effects is by administering the vaccine along with certain drugs. In one of its study arms, subjects are given acetaminophen every six hours for the first 24 hours after inoculation. The pain and fever reducer could potentially mask and downplay side effects such as pain, fever, headache or general malaise.<\/p>\n<p>In addition to masking side effects, it is widely recognized among literate natural medicine physicians that using <a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2014\/03\/26\/acetaminophen-overdose.aspx\">acetaminophen<\/a> during acute viral infections is not a wise strategy as it impairs the immune response to fight the infection.<\/p>\n<div class=\"video-rwd\">\n<figure class=\"op-interactive aspect-ratio\"><iframe loading=\"lazy\" id=\"iFrameResizer0\" class=\" mlazyloaded\" src=\"https:\/\/www.youtube.com\/embed\/dT6mHi_8V5E?start=417&amp;wmode=transparent&amp;rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" scrolling=\"no\" allowfullscreen=\"allowfullscreen\" data-mlazyload-src=\"https:\/\/www.youtube.com\/embed\/dT6mHi_8V5E?start=417&amp;wmode=transparent&amp;rel=0\" data-mce-fragment=\"1\"><\/iframe><\/figure>\n<\/div>\n<p>As reported by Wired:<sup><span id=\"edn7\" data-hash=\"#ednref7\">7<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cThe press release for \u2026 results from the Oxford vaccine trials described an increased frequency of \u2018minor side effects\u2019 among participants. A look at the actual paper, though, reveals this to be a marketing spin \u2026<\/em><\/p><\/blockquote>\n<blockquote><p><em>Yes, mild reactions were far more common than worse ones. But moderate or severe harms \u2014 defined as being bad enough to interfere with daily life or needing medical care \u2014 were common too. <\/em><\/p><\/blockquote>\n<blockquote><p><em>Around one-third of people vaccinated with the COVID-19 vaccine without acetaminophen experienced moderate or severe chills, fatigue, headache, malaise, and\/or feverishness. <\/em><\/p><\/blockquote>\n<blockquote><p><em>Close to 10 percent had a fever of at least 100.4 degrees, and just over one-fourth developed moderate or severe muscle aches. That\u2019s a lot, in a young and healthy group of people \u2014 and the acetaminophen didn\u2019t help much for most of those problems.\u201d<\/em><\/p><\/blockquote>\n<h2>Two Trials Paused Due to Safety Concerns<\/h2>\n<p>September 6, 2020, AstraZeneca paused its Phase 3 vaccine trial due to a \u201csuspected serious and unexpected adverse reaction\u201d in a British participant.<sup><span id=\"edn8\" data-hash=\"#ednref8\">8<\/span>,<\/sup><sup><span id=\"edn9\" data-hash=\"#ednref9\">9<\/span><\/sup> The company did not initially divulge the nature of the adverse reaction, but it has since been revealed the volunteer developed severe inflammation of the spinal cord, known as transverse myelitis.<sup><span id=\"edn10\" data-hash=\"#ednref10\">10<\/span>,<\/sup><sup><span id=\"edn11\" data-hash=\"#ednref11\">11<\/span><\/sup><\/p>\n<p>September 12, 2020, the British Medicines Health Regulatory Authority gave AstraZeneca the go-ahead to resume its Phase 3 trial in the U.K., after an independent review found it \u201csafe to do so.\u201d<sup><span id=\"edn12\" data-hash=\"#ednref12\">12<\/span>,<\/sup><sup><span id=\"edn13\" data-hash=\"#ednref13\">13<\/span><\/sup> According to an AstraZeneca spokesperson, the incident was a case of undiagnosed multiple sclerosis.<sup><span id=\"edn14\" data-hash=\"#ednref14\">14<\/span><\/sup><\/p>\n<p>Days later, September 19, 2020, The New York Times reported<sup><span id=\"edn15\" data-hash=\"#ednref15\">15<\/span><\/sup> a second case of transverse myelitis had occurred in the AstraZeneca trial. According to one expert consulted by the NYT, the occurrence represented a \u201cdangerous pattern,\u201d and that a third incidence might shut down the vaccine trial indefinitely.<\/p>\n<p>AstraZeneca, however, claims the two cases are \u201cunlikely to be associated with the vaccine,\u201d and that there\u2019s \u201cinsufficient evidence to say for certain that the illnesses were or were not related to the vaccine.\u201d<sup><span id=\"edn16\" data-hash=\"#ednref16\">16<\/span><\/sup> October 21, 2020, it was reported<sup><span id=\"edn17\" data-hash=\"#ednref17\">17<\/span><\/sup> that one of the volunteers in AstraZeneca\u2019s Brazilian trial had died from COVID-19 complications, but that the trial would continue anyway.<\/p>\n<p>October 12, 2020, Johnson &amp; Johnson halted its trial due to \u201cunexplained illness\u201d in one of its participants.<sup><span id=\"edn18\" data-hash=\"#ednref18\">18<\/span>,<\/sup><sup><span id=\"edn19\" data-hash=\"#ednref19\">19<\/span><\/sup> Like AstraZeneca, Johnson &amp; Johnson has kept mum about the details of the illness, saying \u201cit\u2019s important to have all the facts before we share additional information.\u201d<\/p>\n<h2>Side Effects Are Commonplace<\/h2>\n<p>The fact that more trials have not been halted is surprising considering the rate of side effects<sup><span id=\"edn20\" data-hash=\"#ednref20\">20<\/span><\/sup> occurring in perfectly healthy volunteers. As reported in \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/08\/04\/side-effects-of-fast-tracked-vaccine.aspx\">Gates Tries to Justify Side Effects of Fast-Tracked Vaccine<\/a>,\u201d after the first of two doses of the <a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/06\/23\/moderna-vaccine-coronavirus.aspx\">Moderna COVID-19 vaccine<\/a>, 80% of Phase 1 participants receiving the 100 microgram (mcg) dose developed systemic side effects.<sup><span id=\"edn21\" data-hash=\"#ednref21\">21<\/span><\/sup><\/p>\n<p>After the second dose, 100% reported side effects ranging from fatigue (80%), chills (80%), headache (60%) and myalgia or muscle pain (53%).<\/p>\n<p>Despite that, the 100-mcg dose was ultimately chosen to move on to Phase 3 trials.<sup><span id=\"edn22\" data-hash=\"#ednref22\">22<\/span><\/sup> In the highest dosage group, which received 250 mcg, 100% of participants suffered side effects after both the first and second doses.<sup><span id=\"edn23\" data-hash=\"#ednref23\">23<\/span><\/sup> Three of the 14 participants (21%) in the 250-mcg group suffered \u201cone or more severe events.\u201d<\/p>\n<p>An October 1, 2020, report<sup><span id=\"edn24\" data-hash=\"#ednref24\">24<\/span><\/sup> by CNBC reviews the experiences of five participants in Moderna\u2019s and Pfizer\u2019s SARS-CoV-2 vaccine trials. One of the participants in Pfizer\u2019s vaccine trial \u201cwoke up with chills, shaking so hard he cracked a tooth after taking the second dose.\u201d<\/p>\n<p>A Moderna trial participant told CNBC he had a low-grade fever and felt \u201cunder the weather\u201d for several days after his first shot. Eight hours after his second shot he was \u201cbed-bound with a fever of over 101, shakes, chills, a pounding headache and shortness of breath. He said the pain in his arm, where he received the shot, felt like a \u2018goose egg on my shoulder.\u2019 He hardly slept that night, recording that his temperature was higher than 100 degrees for five hours.\u201d<sup><span id=\"edn25\" data-hash=\"#ednref25\">25<\/span><\/sup><\/p>\n<p>Two others reported similar side effects, and a third warned you would need to take a day off after the second shot. CNBC also noted that \u201cas companies progressed through clinical trials, several vaccine makers abandoned their highest doses following reports of more severe reactions.\u201d<\/p>\n<h2>Might Certain COVID-19 Vaccines Raise Risk of AIDS?<\/h2>\n<p>Disturbingly, a group of researchers are now expressing concern that some COVID-19 vaccine candidates might put certain people at a higher risk of acquiring HIV, the virus that causes AIDS.<sup><span id=\"edn26\" data-hash=\"#ednref26\">26<\/span>,<\/sup><sup><span id=\"edn27\" data-hash=\"#ednref27\">27<\/span>,<\/sup><sup><span id=\"edn28\" data-hash=\"#ednref28\">28<\/span><\/sup><\/p>\n<p>Using the failed attempt to create an HIV vaccine as an example, researchers explain<sup><span id=\"edn29\" data-hash=\"#ednref29\">29<\/span><\/sup> that the genetically engineered adenovirus, Ad5, used in the HIV vaccine trials, is the same one being used now in four COVID-19 candidates being studied in the U.S., Russia and Pakistan.<\/p>\n<p>At the time of the failed HIV vaccine, scientists were unable to identify the exact reason why Ad5 seemed to increase the risk of HIV; it just inexplicably did. Interestingly, Dr. Anthony Fauci was the lead author on the HIV study,<sup><span id=\"edn30\" data-hash=\"#ednref30\">30<\/span><\/sup> in which he questioned \u201cwhether the problem extends to some or all of the other recombinant vectors currently in development or to other vector-based vaccines.\u201d<\/p>\n<p>Reflecting on that question, the researchers say they decided to go public with this information now, because Ad5 vaccines for COVID-19 might soon be tested in populations with high HIV prevalence, and they believe that informed consent about the HIV\/AIDS risk should be part of the COVID-19 clinical studies.<\/p>\n<h2>Will COVID-19 Vaccine Be Mandatory?<\/h2>\n<p>According to one September 2020 poll,<sup><span id=\"edn31\" data-hash=\"#ednref31\">31<\/span><\/sup> only 51% of Americans said they \u201cdefinitely or probably\u201d would get the COVID-19 vaccine when it comes out. Another survey<sup><span id=\"edn32\" data-hash=\"#ednref32\">32<\/span><\/sup> found only 44% would take the first-generation vaccine even if they were paid $100. Mounting vaccine hesitancy was bemoaned in an October 1, 2020, article<sup><span id=\"edn33\" data-hash=\"#ednref33\">33<\/span><\/sup> in the New England Journal of Medicine, and the answer, the article suggests, is to make it mandatory for all.<\/p>\n<p>And, to entice compliance, the authors recommend implementing severe penalties for noncompliance, such as the suspension of employment and\/or house arrest.<\/p>\n<p>An October 19, 2020, article<sup><span id=\"edn34\" data-hash=\"#ednref34\"> 34<\/span><\/sup> by Wisconsin Public Radio also warns that if precedents hold, employers may have the right to force workers to get vaccinated. Potential exceptions might include certain medical issues, bona fide religious objections, and certain union contracts that bar vaccine requirements.<\/p>\n<p>Operation Warp Speed recently selected Walgreens and CVS as nationwide partners in the coming vaccine distribution effort.<sup><span id=\"edn35\" data-hash=\"#ednref35\">35<\/span><\/sup> Nursing homes and long-term care facilities around the U.S. can opt in by signing up to have either of these companies come and administer the vaccine to its residents and staff, once available.<\/p>\n<p>So-called \u201chealth passports\u201d are also becoming reality. Ireland, for example, has already begun its national trial. The <a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/10\/06\/health-passports-for-ireland.aspx\">Health Passport Ireland initiative<\/a> uses an app to track and display results of COVID-19 testing. Vaccination status will be added once a vaccine becomes available.<\/p>\n<p>Untold amounts of money are also being spent on programs to <a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/09\/15\/profusa-injectable-biosensors.aspx\">tag, track and trace the human population<\/a> in the name of public health and safety. According to an article<sup><span id=\"edn36\" data-hash=\"#ednref36\">36<\/span><\/sup> in the journal JAMA, the estimated cumulative costs of the COVID-19 pandemic related to lost output and health reduction amounts to more than $16 trillion in the U.S. alone, or about 90% of our annual gross domestic product.<\/p>\n<p>\u201cFor this reason, policies that can materially reduce the spread of SARS-CoV-2 have enormous social value,\u201d the article claims. However, testing, tracing and isolation rules, all of which are promoted in this article, also have a price, and it\u2019s one that any sensible person would reject, namely the loss of privacy and liberty.<\/p>\n<p>As reported<sup><span id=\"edn37\" data-hash=\"#ednref37\">37<\/span><\/sup> by The Last American Vagabond, governments are selling our freedom in the name of public health. Do we really want to live in a \u201cbiosecurity state\u201d? These freedom-robbing strategies are being sold to us as the path back to normalcy, but the reality will be anything but normal.<\/p>\n<p>As detailed in \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/10\/23\/world-economic-forum-prediction-global-takeover.aspx\">The Global Takeover Is Underway<\/a>,\u201d the pandemic and the global response to it is far from accidental. Overwhelmingly, the evidence points to it being part of a much larger scheme to implement the last stages of a technocratic takeover.<\/p>\n<p>I\u2019ve also covered various aspects of this globalists agenda in \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/05\/27\/tech-companies-coronavirus.aspx\">COVID Symptoms of Power: Tech Billionaires Harvest Humanity<\/a>,\u201d \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/06\/03\/mojaloop.aspx\">Tech Billionaires Aiming at a Global Currency<\/a>,\u201d \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/05\/17\/surveillance-capitalism.aspx\">Harvard Professor Exposes Surveillance Capitalism<\/a>,\u201d \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/09\/05\/medical-technocracy.aspx\">How Medical Technocracy Made the Plandemic Possible<\/a>\u201d and \u201c<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/06\/02\/hr-6666-covid-19-government-surveillance.aspx\">US Surveillance Bill 6666: The Devil in the Details<\/a>.\u201d<\/p>\n<p>The COVID-19 pandemic has dramatically widened the economic gap between average people and the wealthy elite,<sup><span id=\"edn38\" data-hash=\"#ednref38\">38<\/span>,<\/sup><sup><span id=\"edn39\" data-hash=\"#ednref39\">39<\/span><\/sup> and continuing down the path we\u2019re currently on will only make this disparity worse, not better.<\/p>\n<p>The globalist plan isn\u2019t about creating a better world for the average person, it\u2019s about enslaving us so that we cannot reject or even resist what\u2019s ultimately coming. Forced vaccinations are but one aspect of the plan that must be resisted at all cost.<\/p>\n<\/div>\n<h2>One of the Most Powerful Videos I&#8217;ve Ever Seen<\/h2>\n<p>The following video from Barbara Loe Fisher is one of the most powerful videos that I have ever seen. I am hopeful that watching this video will inspire you to take up the cause and join the fight for vaccine freedom and independence.<\/p>\n<p>There is a cultural war and collusion between many industries and federal regulatory agencies that results in a suppression of the truth about vital important health issues. If this suppression continues we will gradually and progressively erode our private individual rights that our ancestors fought so hard to achieve. Please take a few minutes to watch this video.<\/p>\n<div class=\"video-rwd\">\n<figure class=\"aspect-ratio\"><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/xEcYQydhY9E?wmode=transparent&amp;rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\" data-mce-fragment=\"1\"><\/iframe><\/figure>\n<\/div>\n<h2>Protect Your Right to Informed Consent and Defend Vaccine Exemptions<\/h2>\n<p>With all the uncertainty surrounding the safety and efficacy of vaccines, it&#8217;s critical to protect your right to make independent health choices and exercise voluntary informed consent to vaccination. It is urgent that everyone in America stand up and fight to protect and expand vaccine informed consent protections in state public health and employment laws. The best way to do this is to get personally involved with your state legislators and educate the leaders in your community.<\/p>\n<h2>Think Globally, Act Locally<\/h2>\n<p>National vaccine policy recommendations are made at the federal level but vaccine laws are made at the state level. It is at the state level where your action to protect your vaccine choice rights can have the greatest impact.<\/p>\n<p>It is critical for EVERYONE to get involved now in standing up for the legal right to make voluntary vaccine choices in America because those choices are being threatened by lobbyists representing drug companies, medical trade associations and public health officials, who are trying to persuade legislators to strip all vaccine exemptions from public health laws.<\/p>\n<p>Signing up for NVIC&#8217;s free Advocacy Portal at <a href=\"https:\/\/nvicadvocacy.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">www.NVICAdvocacy.org<\/a> gives you immediate, easy access to your own state legislators on your smartphone or computer so you can make your voice heard. You will be kept up to date on the latest state bills threatening your vaccine choice rights and will get practical, useful information to help you become an effective vaccine choice advocate in your own community.<\/p>\n<p>Also, when national vaccine issues come up, you will have the up-to-date information and call-to-action items you need at your fingertips. So, please, as your first step, sign up for the NVIC Advocacy Portal.<\/p>\n<p><a class=\"blue-btn\" href=\"http:\/\/nvicadvocacy.org\/members\/Home.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">JOIN THE NVIC ADVOCACY PORTAL<\/a><\/p>\n<h2>Share Your Story With the Media and People You Know<\/h2>\n<p>If you or a family member has suffered a serious vaccine reaction, injury or death, please talk about it. If we don&#8217;t share information and experiences with one another, everybody feels alone and afraid to speak up. Write a letter to the editor if you have a different perspective on a vaccine story that appears in your local newspaper. Make a call in to a radio talk show that is presenting only one side of the vaccine story.<\/p>\n<p>I must be frank with you: You have to be brave because you might be strongly criticized for daring to talk about the &#8220;other side&#8221; of the vaccine story. Be prepared for it and have the courage to not back down. Only by sharing our perspective and what we know to be true about vaccination will the public conversation about vaccination open up so people are not afraid to talk about it.<\/p>\n<p>We cannot allow the drug companies and medical trade associations funded by drug companies or public health officials promoting forced use of a growing list of vaccines to dominate the conversation about vaccination.<\/p>\n<p>The vaccine injured cannot be swept under the carpet and treated like nothing more than &#8220;statistically acceptable collateral damage&#8221; of national one-size-fits-all mandatory vaccination policies that put way too many people at risk for injury and death. We shouldn&#8217;t be treating people like guinea pigs instead of human beings.<\/p>\n<h2>Internet Resources Where You Can Learn More<\/h2>\n<p>I encourage you to visit the website of the nonprofit charity, the National Vaccine Information Center (NVIC), at <a href=\"https:\/\/www.nvic.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">www.NVIC.org<\/a>:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.nvic.org\/Vaccine-Laws\/state-vaccine-requirements.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Vaccine Requirements and Exemptions by State<\/strong><\/a> \u2014 Vaccine laws vary from one U.S. state to another. By knowing the specific policies where you live, you\u2019ll learn how you can get exemptions and better protect your right to make informed vaccine choices.<\/li>\n<li><a href=\"https:\/\/www.nvic.org\/Vaccine-Memorial.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>NVIC Memorial for Vaccine Victims<\/strong><\/a> \u2014 View descriptions and photos of children and adults who have suffered vaccine reactions, injuries and deaths. If you or your child experiences an adverse vaccine event, please consider posting and sharing your story here.<\/li>\n<li><a href=\"https:\/\/www.nvic.org\/Ask-Eight-Questions.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>If You Vaccinate, Ask 8 Questions<\/strong><\/a> \u2014 Learn how to recognize vaccine reaction symptoms and prevent vaccine injuries.<\/li>\n<li><a href=\"https:\/\/www.nvic.org\/Forms\/Cry-For-Vaccine-Freedom-Wall.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Vaccine Freedom Wall <\/strong><\/a> \u2014 View or post descriptions of harassment and sanctions by doctors, employers and school and health officials for making independent vaccine choices.<\/li>\n<li><a href=\"https:\/\/www.nvic.org\/forms\/vaccine-failure-wall.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Vaccine Failure Wall<\/strong><\/a> \u2014 View or post descriptions about vaccines that have failed to work and protect the vaccinated from disease.<\/li>\n<\/ul>\n<h2>Connect With Your Doctor or Find a New One Who Will Listen and Care<\/h2>\n<p>If your pediatrician or doctor refuses to provide medical care to you or your child unless you agree to get vaccines you don&#8217;t want, I strongly encourage you to have the courage to find another doctor.<\/p>\n<p>Harassment, intimidation and refusal of medical care are becoming the modus operandi of the medical establishment in an effort to stop the change in attitude of many parents about vaccinations after they become truly educated about health and vaccination. However, there is hope.<\/p>\n<p>At least 15% of young doctors recently polled admit that they&#8217;re starting to adopt a more individualized approach to vaccinations in direct response to the vaccine safety concerns of parents.<\/p>\n<p>It is good news that there is a growing number of smart young doctors who prefer to work as partners with parents in making personalized vaccine decisions for children, including delaying vaccinations or giving children fewer vaccines on the same day, or continuing to provide medical care for those families who decline use of one or more vaccines.<\/p>\n<p>So, take the time to locate a doctor who treats you with compassion and respect, and who is willing to work with you to do what is right for your child.<\/p>\n<h2>Subscribe to the Mercola Newsletter to Get Timely Vaccine News and Updates<\/h2>\n<p>Google has been censoring vaccine information providers, which means finding reliable information about this topic can be a real challenge.<\/p>\n<p>To help you keep updated on vaccine issues and exemptions, I invite you to subscribe to my FREE health newsletter. You will receive the latest health news from Mercola.com straight to your inbox, with no threats to your security and privacy.<\/p>\n<div id=\"article\" data-swiftype-name=\"postbody\" data-swiftype-type=\"text\">\n<div id=\"bcr_Upanel\">\n<div id=\"bcr_divfootnote\" class=\"sources-references narrow-width\">\n<h3 id=\"heading\" class=\"title link16\" data-jsid=\"sourcesReferencesBtn\">&#8211; Sources and References<\/h3>\n<div id=\"contentrefsources\" class=\"contentrefsources\" data-jsid=\"sourcesReferences\">\n<div id=\"bcr_divReferences\" class=\"references\">\n<ul id=\"footnote-references2\">\n<li><sup><span id=\"ednref1\" data-hash=\"#edn1\"><span id=\"lblReferenceNo\">1,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref2\" data-hash=\"#edn2\"><span id=\"lblReferenceNo\">2,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref3\" data-hash=\"#edn3\"><span id=\"lblReferenceNo\">3,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref4\" data-hash=\"#edn4\"><span id=\"lblReferenceNo\">4<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.forbes.com\/sites\/williamhaseltine\/2020\/09\/23\/covid-19-vaccine-protocols-reveal-that-trials-are-designed-to-succeed\/amp\/?__twitter_impression=true\" target=\"_blank\" rel=\"noopener noreferrer\">Forbes September 23, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref5\" data-hash=\"#edn5\"><span id=\"lblReferenceNo\">5<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.henryford.com\/moderna-vaccine\/faqs#WhatisStudy\" target=\"_blank\" rel=\"noopener noreferrer\">Henryford.com Moderna COVE Vaccine Study <\/a><\/li>\n<li><sup><span id=\"ednref6\" data-hash=\"#edn6\"><span id=\"lblReferenceNo\">6,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref7\" data-hash=\"#edn7\"><span id=\"lblReferenceNo\">7<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.wired.com\/story\/covid-19-vaccines-with-minor-side-effects-could-still-be-pretty-bad\/?fbclid=IwAR2y8lFUO7KaJLop4wpwGCAqALLufZs6RmFDxWLueB8rjUAyVSz80vy53cg\" target=\"_blank\" rel=\"noopener noreferrer\">Wired July 21, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref8\" data-hash=\"#edn8\"><span id=\"lblReferenceNo\">8,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref12\" data-hash=\"#edn12\"><span id=\"lblReferenceNo\">12<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.astrazeneca.com\/content\/astraz\/media-centre\/press-releases\/2020\/covid-19-vaccine-azd1222-clinical-trials-resumed-in-the-uk.html\" target=\"_blank\" rel=\"noopener noreferrer\">AstraZeneca September 12, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref9\" data-hash=\"#edn9\"><span id=\"lblReferenceNo\">9<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.statnews.com\/2020\/09\/08\/astrazeneca-covid-19-vaccine-study-put-on-hold-due-to-suspected-adverse-reaction-in-participant-in-the-u-k\/\" target=\"_blank\" rel=\"noopener noreferrer\">STAT News September 8, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref10\" data-hash=\"#edn10\"><span id=\"lblReferenceNo\">10<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/khn.org\/news\/nih-and-fda-examine-serious-side-effect-that-surfaced-in-covid-vaccine-trial\/\" target=\"_blank\" rel=\"noopener noreferrer\">KHN September 14, 2020<\/a><\/li>\n<li><sup><span id=\"ednref11\" data-hash=\"#edn11\"><span id=\"lblReferenceNo\">11<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/archive.is\/fymqJ#selection-735.237-735.377\" target=\"_blank\" rel=\"noopener noreferrer\">New York Times September 8, 2020 (Archived) <\/a><\/li>\n<li><sup><span id=\"ednref13\" data-hash=\"#edn13\"><span id=\"lblReferenceNo\">13<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.statnews.com\/2020\/09\/12\/astrazeneca-covid19-vaccine-trial-resumes-uk\/\" target=\"_blank\" rel=\"noopener noreferrer\">STAT News September 12, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref14\" data-hash=\"#edn14\"><span id=\"lblReferenceNo\">14<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/en.as.com\/en\/2020\/09\/21\/latest_news\/1600676472_693398.html\" target=\"_blank\" rel=\"noopener noreferrer\">En.as.com September 21, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref15\" data-hash=\"#edn15\"><span id=\"lblReferenceNo\">15<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/archive.is\/aFI7m\" target=\"_blank\" rel=\"noopener noreferrer\">The New York Times September 19, 2020 (Archived) <\/a><\/li>\n<li><sup><span id=\"ednref16\" data-hash=\"#edn16\"><span id=\"lblReferenceNo\">16<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/covid19vaccinetrial.co.uk\/files\/cov002pisages18-55yearsv11011sept2020pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Covid19vaccinetrial.co.uk Participant Information Sheet (PDF) <\/a><\/li>\n<li><sup><span id=\"ednref17\" data-hash=\"#edn17\"><span id=\"lblReferenceNo\">17<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.reuters.com\/article\/us-health-coronavirus-brazil-vaccine-idUSKBN2762MO?fbclid=IwAR1z6a5xC1j77ZkCXwfNyAuGlDXPgcfDw-g04Db4t5suR9IO91i06fBrdyQ\" target=\"_blank\" rel=\"noopener noreferrer\">Reuters October 21, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref18\" data-hash=\"#edn18\"><span id=\"lblReferenceNo\">18<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.jnj.com\/our-company\/johnson-johnson-temporarily-pauses-all-dosing-in-our-janssen-covid-19-vaccine-candidate-clinical-trials\" target=\"_blank\" rel=\"noopener noreferrer\">JnJ.com <\/a><\/li>\n<li><sup><span id=\"ednref19\" data-hash=\"#edn19\"><span id=\"lblReferenceNo\">19<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.channel3000.com\/a-week-after-covid-19-vaccine-trial-goes-on-pause-johnson-johnson-and-fda-wont-reveal-critical-details\/\" target=\"_blank\" rel=\"noopener noreferrer\">Channel3000 October 19, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref20\" data-hash=\"#edn20\"><span id=\"lblReferenceNo\">20<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/observer.com\/2020\/10\/vaccine-side-effects-moderna-pfizer-johnson-astrazeneca\/\" target=\"_blank\" rel=\"noopener noreferrer\">Observer October 20, 2020<\/a><\/li>\n<li><sup><span id=\"ednref21\" data-hash=\"#edn21\"><span id=\"lblReferenceNo\">21<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2022483\" target=\"_blank\" rel=\"noopener noreferrer\">NEJM July 14, 2020 DOI: 10.1056\/NEJMoa2022483<\/a><\/li>\n<li><sup><span id=\"ednref22\" data-hash=\"#edn22\"><span id=\"lblReferenceNo\">22<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.neurologylive.com\/view\/moderna-covid19-vaccine-shows-promise-moves-to-phase-3\" target=\"_blank\" rel=\"noopener noreferrer\">Neurology Live July 16, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref23\" data-hash=\"#edn23\"><span id=\"lblReferenceNo\">23<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.reporter.am\/moderna-coronavirus-vaccine-shows-promising-results-in-published-phase-1-study\/\" target=\"_blank\" rel=\"noopener noreferrer\">Reporter.am July 14, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref24\" data-hash=\"#edn24\"><span id=\"lblReferenceNo\">24,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref25\" data-hash=\"#edn25\"><span id=\"lblReferenceNo\">25<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.cnbc.com\/2020\/10\/01\/coronavirus-vaccine-trial-participants-exhaustion-fever-headaches.html\" target=\"_blank\" rel=\"noopener noreferrer\">CNBC October 4, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref26\" data-hash=\"#edn26\"><span id=\"lblReferenceNo\">26,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref29\" data-hash=\"#edn29\"><span id=\"lblReferenceNo\">29<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(20)32156-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Lancet October 19, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref27\" data-hash=\"#edn27\"><span id=\"lblReferenceNo\">27<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.forbes.com\/sites\/roberthart\/2020\/10\/20\/researchers-warn-some-covid-19-vaccines-could-increase-risk-of-hiv-infection\/?utm_campaign=forbes&amp;utm_source=facebook&amp;utm_medium=social&amp;utm_term=Gordie%2F&amp;fbclid=IwAR2ktEMlxhxPFSFDPyKo2KLOlWbedag9#2b\" target=\"_blank\" rel=\"noopener noreferrer\">Forbes October 20, 2020<\/a><\/li>\n<li><sup><span id=\"ednref28\" data-hash=\"#edn28\"><span id=\"lblReferenceNo\">28<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.sciencemag.org\/news\/2020\/10\/could-certain-covid-19-vaccines-leave-people-more-vulnerable-aids-virus\" target=\"_blank\" rel=\"noopener noreferrer\">Science October 19, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref30\" data-hash=\"#edn30\"><span id=\"lblReferenceNo\">30<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/science.sciencemag.org\/content\/344\/6179\/49\" target=\"_blank\" rel=\"noopener noreferrer\">Science April 4, 2014; 344(6179): 49-51 <\/a><\/li>\n<li><sup><span id=\"ednref31\" data-hash=\"#edn31\"><span id=\"lblReferenceNo\">31<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.cidrap.umn.edu\/news-perspective\/2020\/09\/americans-increasingly-skeptical-covid-vaccine-poll-finds\" target=\"_blank\" rel=\"noopener noreferrer\">CIDRAP September 18, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref32\" data-hash=\"#edn32\"><span id=\"lblReferenceNo\">32<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.axios.com\/axios-ipsos-poll-trump-coronavirus-vaccine-06428246-c633-41ba-9081-1f789a90e976.html\" target=\"_blank\" rel=\"noopener noreferrer\">Axios September 24-27, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref33\" data-hash=\"#edn33\"><span id=\"lblReferenceNo\">33<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp2020926?query=recirc_artType_railA_article\" target=\"_blank\" rel=\"noopener noreferrer\">NEJM 2020; 383:1296-1299<\/a><\/li>\n<li><sup><span id=\"ednref34\" data-hash=\"#edn34\"><span id=\"lblReferenceNo\">34<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.wpr.org\/can-your-boss-require-you-get-covid-19-vaccine-when-its-released\" target=\"_blank\" rel=\"noopener noreferrer\">Wisconsin Public Radio October 19, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref35\" data-hash=\"#edn35\"><span id=\"lblReferenceNo\">35<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.defense.gov\/Explore\/News\/Article\/Article\/2385260\/dod-hhs-name-partners-to-administer-covid-19-vaccines-in-long-term-care-facilit\/source\/GovDelivery\/\" target=\"_blank\" rel=\"noopener noreferrer\">Defense.gov October 17, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref36\" data-hash=\"#edn36\"><span id=\"lblReferenceNo\">36<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2771764?guestAccessKey=051180f0-a47c-4faf-8049-2beef6526be7&amp;utm_source=For_The_Media&amp;utm_medium=referral&amp;utm_campaign=ftm_links&amp;utm_content=tfl&amp;utm_term=101220\" target=\"_blank\" rel=\"noopener noreferrer\">JAMA 2020;324(15):1495-1496<\/a><\/li>\n<li><sup><span id=\"ednref37\" data-hash=\"#edn37\"><span id=\"lblReferenceNo\">37<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.thelastamericanvagabond.com\/u-s-government-awards-contracts-to-seven-organizations-with-ties-to-gates-foundation-darpa-big-tech\/\" target=\"_blank\" rel=\"noopener noreferrer\">The Last American Vagabond October 13, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref38\" data-hash=\"#edn38\"><span id=\"lblReferenceNo\">38<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.thenation.com\/article\/economy\/bill-gates-investments-covid\/tnamp\/?__twitter_impression=true\" target=\"_blank\" rel=\"noopener noreferrer\">The Nation October 5, 2020 <\/a><\/li>\n<li><sup><span id=\"ednref39\" data-hash=\"#edn39\"><span id=\"lblReferenceNo\">39<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.theguardian.com\/business\/2020\/oct\/07\/covid-19-crisis-boosts-the-fortunes-of-worlds-billionaires\" target=\"_blank\" rel=\"noopener noreferrer\">The Guardian October 6, 2020 <\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"clear\"><span style=\"font-size: 16px;\">___<br \/>\n<\/span><a style=\"font-size: 16px;\" href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/10\/27\/covid-vaccine-trials.aspx\">https:\/\/articles.mercola.com\/sites\/articles\/archive\/2020\/10\/27\/covid-vaccine-trials.aspx<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>How COVID-19 Vaccine Trials Are Rigged<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-33746","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/33746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33746"}],"version-history":[{"count":0,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/33746\/revisions"}],"wp:attachment":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33746"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}